Salvinicins A and B, new neoclerodane diterpenes from Salvia divinorum.
about
Synthetic studies of neoclerodane diterpenes from Salvia divinorum: semisynthesis of salvinicins A and B and other chemical transformations of salvinorin AHerkinorin analogues with differential beta-arrestin-2 interactionsSynthetic studies of neoclerodane diterpenes from Salvia divinorum: exploration of the 1-positionSalvinorin A analogs as probes in opioid pharmacology.Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin AUnusual hemiacetal structure derived from Salvinorin A.Chemical methods for the synthesis and modification of neoclerodane diterpenesSynthesis and biological evaluation of C-2 halogenated analogs of salvinorin A.Short synthesis of a novel class of salvinorin A analogs with hemiacetalic structure.Neoclerodanes as atypical opioid receptor ligandsNatural products as tools for neuroscience: discovery and development of novel agents to treat drug abuseAutoxidation of salvinorin A under basic conditions.Synthesis of deacetyl-1,10-didehydrosalvinorin G.Salvia divinorum: An overview of the usage, misuse, and addiction processes.Molecular Signaling Pathways Behind the Biological Effects of Salvia Species Diterpenes in Neuropharmacology and Cardiology.Clerodane diterpenes: sources, structures, and biological activities.Novel neoclerodane diterpene derivatives from the smoke of salvinorin A.Salvia divinorum use and phenomenology: results from an online survey.The C-2 derivatives of salvinorin A, ethoxymethyl ether Sal B and β-tetrahydropyran Sal B, have anti-cocaine properties with minimal side effects.
P2860
Q24647224-39761B81-81A1-483A-8A46-8A30C5AE1B47Q24649793-75717057-4E1C-4259-801E-F70ABA187570Q24681800-902A45B9-1180-4D67-8D42-1993ABE2B144Q30439719-453CD56A-E261-4143-8B46-FC6356B325CFQ30467220-161B8AA0-E37A-4F6B-96C9-F04070381303Q34229894-AC4E33C4-1C39-4842-B92F-53E53A1EE838Q34296387-976F43C7-CB24-4C05-9453-E492C0F31354Q35887833-4B1F391B-C535-4F97-9204-CD34A6B8A2FDQ36591849-230A87D5-D41B-4276-9701-C0A5F76ACA1CQ36899819-11BEF5C3-7105-4FDF-8025-022F726C287AQ37355904-7F90356B-FE5B-4245-923B-A05756F83686Q37422833-E07C9154-E116-4866-A00F-431D2DE09B13Q38570224-01D20BA2-5131-41C4-B933-6E274D3384B7Q38652778-72731C6F-6E80-450D-9443-6628268A2DCFQ38778876-5DE518EA-4646-4A52-BF75-41F245203020Q38902043-58FF0FB6-F15B-40B6-B641-7F08AFAD0F81Q42286399-55FF7C40-A779-4CAB-A652-DCEDDFB90569Q44641835-217849C3-5526-417D-8DA5-6002855E0737Q47878237-A29AE6A7-94C9-4926-9132-51496D4183BD
P2860
Salvinicins A and B, new neoclerodane diterpenes from Salvia divinorum.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Salvinicins A and B, new neoclerodane diterpenes from Salvia divinorum.
@en
type
label
Salvinicins A and B, new neoclerodane diterpenes from Salvia divinorum.
@en
prefLabel
Salvinicins A and B, new neoclerodane diterpenes from Salvia divinorum.
@en
P2093
P2860
P356
P1433
P1476
Salvinicins A and B, new neoclerodane diterpenes from Salvia divinorum.
@en
P2093
Christina M Dersch
Damon Parrish
Jeffrey R Deschamps
John Snyder
Kevin Tidgewell
Kushal Shah
Matthew Schmidt
Richard B Rothman
Thomas E Prisinzano
Wayne W Harding
P2860
P304
P356
10.1021/OL0510522
P407
P577
2005-07-01T00:00:00Z